HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Hims & Hers Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$28.15+0.08 (+0.29%)
Close on Oct 19, 2026
- Market cap
- $6.52B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
67.1%
157M of 233M shares
Institutional holders
506
143 new, 66 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
1 buys · 43 sales
Net sold $17.98M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 26,496,218 | 11.90% | 13G (passive) amendment | Jun 30, 2026 |
| Andrew Dudum | 22,610,002 | 9.40% | 13D (active) amendment | Aug 27, 2026 |
| Susquehanna Securities, LLC | 14,502,395 | 6.50% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 11,188,807 | 5.01% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HIMS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,703,514 | 12.30% | $995.15M | +2,366,356 | 0.01% |
| Vanguard Portfolio Management LLC | 10,559,314 | 4.53% | $366.09M | +375,501 | 0.02% |
| Vanguard Capital Management LLC | 9,541,384 | 4.09% | $330.80M | +201,673 | 0.01% |
| State Street Corp | 8,145,699 | 3.49% | $282.41M | +685,676 | 0.01% |
| Morgan Stanley | 7,152,498 | 3.07% | $247.98M | −1,736,590 | 0.01% |
| Divisadero Street Capital Management, LP | 6,009,505 | 2.58% | $208.35M | +5,539,672 | 4.72% |
| Geode Capital Management, LLC | 5,681,832 | 2.44% | $197.02M | +483,053 | 0.01% |
| Goldman Sachs Group Inc | 5,173,865 | 2.22% | $179.38M | +2,719,170 | 0.02% |
| JPMorgan Chase & Co | 4,766,781 | 2.04% | $159.48M | −474,035 | 0.01% |
| FMR LLC | 4,323,292 | 1.85% | $149.89M | +4,230,022 | 0.01% |
| Marshall Wace, Llp | 4,217,767 | 1.81% | $146.23M | +3,493,540 | 0.12% |
| UBS Group AG | 2,660,810 | 1.14% | $92.25M | −1,490,828 | 0.01% |
| Northern Trust Corp | 2,594,277 | 1.11% | $89.94M | +158,248 | 0.01% |
| Charles Schwab Investment Management Inc | 2,453,787 | 1.05% | $85.07M | +95,073 | 0.01% |
| State Of Michigan Retirement System | 2,346,282 | 1.01% | $81.35M | +7,682 | 0.36% |
| Bank Of America Corp /De/ | 2,312,272 | 0.99% | $80.17M | −2,045,400 | 0.01% |
| Principal Financial Group Inc | 1,667,073 | 0.71% | $57.80M | +384,807 | 0.03% |
| Vanguard Fiduciary Trust Co | 1,522,249 | 0.65% | $52.78M | +72,864 | 0.01% |
| Bank of New York Mellon Corp | 1,333,146 | 0.57% | $46.22M | −7,300 | 0.01% |
| Schroder Investment Management Group | 1,129,781 | 0.48% | $37.72M | +397,015 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 506 | 157M | 67.1% | 143 / 179 | 130 / 66 | 37M | 30M |
| Q1 2026 | 436 | 149M | 64.0% | 83 / 159 | 142 / 127 | 52M | 65M |
| Q4 2025 | 487 | 184M | 78.7% | 99 / 178 | 161 / 120 | 21M | 55M |
| Q3 2025 | 512 | 218M | 93.4% | 103 / 201 | 153 / 95 | 65M | 21M |
| Q2 2025 | 510 | 176M | 75.3% | 141 / 187 | 143 / 56 | 40M | 25M |
| Q1 2025 | 430 | 160M | 68.6% | 118 / 146 | 142 / 73 | 34M | 36M |
| Q4 2024 | 394 | 165M | 70.6% | 133 / 129 | 108 / 42 | 62M | 37M |
| Q3 2024 | 308 | 140M | 59.9% | 65 / 103 | 91 / 49 | 40M | 23M |
| Q2 2024 | 297 | 139M | 59.4% | 98 / 109 | 63 / 41 | 44M | 38M |
| Q1 2024 | 243 | 133M | 57.1% | 81 / 70 | 66 / 33 | 35M | 28M |
| Q4 2023 | 197 | 126M | 54.1% | 38 / 71 | 57 / 29 | 22M | 15M |
| Q3 2023 | 191 | 119M | 51.0% | 33 / 72 | 57 / 29 | 10M | 23M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of HIMS | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 7,252,529 | 3.11% | $251.45M | 0.20% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,715,813 | 2.88% | $232.84M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 5,547,245 | 2.38% | $192.32M | 0.23% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,861,892 | 2.08% | $168.56M | 0.09% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,801,108 | 1.20% | $97.11M | 0.21% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,434,622 | 1.04% | $84.41M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,362,481 | 1.01% | $65.61M | 0.19% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,995,034 | 0.86% | $69.17M | 0.45% | Jun 30, 2026 |
| JPMorgan Large Cap Growth Fund | 1,976,939 | 0.85% | $68.54M | 0.06% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 1,268,502 | 0.54% | $43.98M | 0.39% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,229,420 | 0.53% | $34.14M | 0.39% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 1,074,027 | 0.46% | $37.24M | 0.20% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 1,072,800 | 0.46% | $28.05M | 0.07% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 1,053,665 | 0.45% | $27.55M | 0.16% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 999,147 | 0.43% | $26.13M | 0.11% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andrew Dudum | Chief Executive Officer, Director, 10% owner | 16,500,902 | 7.07% | Aug 27, 2026 |
| Deborah M. Autor | Chief Policy Officer, Director | 48,961 | 0.02% | Aug 20, 2026 |
| Oluyemi Okupe | Chief Financial Officer | 244,380 | 0.10% | Sep 23, 2026 |
| Michael Chi | Chief Operating Officer | 456,660 | 0.20% | Sep 17, 2026 |
| Mohamed Elshenawy | CTO | 185,556 | 0.08% | Sep 17, 2026 |
| Soleil Boughton | Chief Legal Officer | 304,270 | 0.13% | Sep 17, 2026 |
| Patrick Harrison Carroll | Chief Medical Officer | 197,847 | 0.08% | Aug 18, 2026 |
| Irene Becklund | PAO | 20,475 | 0.01% | Aug 18, 2026 |
| Nader Kabbani | Chief Operating Officer | – | – | May 20, 2025 |
| Melissa Baird | Chief Operating Officer | 817,829 | 0.35% | May 13, 2025 |
| Christopher D. Payne | Director | 144,863 | 0.06% | Aug 18, 2026 |
| David B. Wells | Director | 229,808 | 0.10% | Aug 18, 2026 |
| Kare Schultz | Director | 26,020 | 0.01% | Aug 18, 2026 |
| Anja Manuel | Director | 38,671 | 0.02% | Aug 14, 2026 |
| Kofi Owusu Amoo-Gottfried | Director | – | – | Aug 14, 2026 |
| Delos M. Cosgrove | Director | 67,995 | 0.03% | Aug 14, 2026 |
| Garcia Andrea G. Perez | Director | 83,822 | 0.04% | Aug 14, 2026 |
| Christiane Pendarvis | Director | 55,430 | 0.02% | Jun 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Oluyemi Okupe Chief Financial Officer | Sep 22, 2026 | Sale(10b5-1 plan) | −29,277 | $29.95 | $876.85K | 236,527 |
| Oluyemi Okupe Chief Financial Officer | Sep 22, 2026 | Option exercise | +14,000 | $5.01 | $70.14K | 265,804 |
| Oluyemi Okupe Chief Financial Officer | Sep 17, 2026 | Sale(10b5-1 plan) | −12,313 | $28.82 | $354.86K | 251,804 |
| Soleil Boughton Chief Legal Officer | Sep 16, 2026 | Sale(10b5-1 plan) | −6,236 | $27.86 | $173.73K | 304,270 |
| Michael Chi Chief Operating Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −14,027 | $28.39 | $398.23K | 456,660 |
| Mohamed Elshenawy CTO | Sep 15, 2026 | Sale(10b5-1 plan) | −7,954 | $28.39 | $225.81K | 185,556 |
| Soleil Boughton Chief Legal Officer | Sep 2, 2026 | Sale(10b5-1 plan) | −3,458 | $28.33 | $97.97K | 310,506 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 27, 2026 | Other | −977,566 | – | – | 103,406 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 25, 2026 | Gift | −463,289 | – | – | 0 |
| Oluyemi Okupe Chief Financial Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −4,938 | $29.99 | $148.09K | 264,117 |
| Oluyemi Okupe Chief Financial Officer | Aug 19, 2026 | Option exercise | +4,938 | $5.01 | $24.74K | 269,055 |
| Soleil Boughton Chief Legal Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −25,111 | $27.55 | $691.81K | 313,964 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 18, 2026 | Sale(10b5-1 plan) | −16,773 | $27.85 | $467.13K | 48,961 |
| Oluyemi Okupe Chief Financial Officer | Aug 17, 2026 | Sale(10b5-1 plan) | −9,388 | $27.89 | $261.83K | 264,117 |
| Oluyemi Okupe Chief Financial Officer | Aug 17, 2026 | Option exercise | +9,388 | $5.01 | $47.03K | 273,505 |
| Michael Chi Chief Operating Officer | Aug 14, 2026 | Tax withholding | −47,702 | $28.15 | $1.34M | 470,687 |
| Michael Chi Chief Operating Officer | Aug 14, 2026 | Option exercise | +86,265 | – | – | 518,389 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 14, 2026 | Tax withholding | −78,859 | $28.15 | $2.22M | 1,033,177 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Aug 14, 2026 | Option exercise | +154,993 | – | – | 1,112,036 |
| Soleil Boughton Chief Legal Officer | Aug 14, 2026 | Option exercise | +42,261 | – | – | 360,575 |
| Soleil Boughton Chief Legal Officer | Aug 14, 2026 | Tax withholding | −21,500 | $28.15 | $605.23K | 339,075 |
| David B. Wells Director | Aug 14, 2026 | Option exercise | +778 | – | – | 229,808 |
| Irene Becklund PAO | Aug 14, 2026 | Option exercise | +13,685 | – | – | 20,475 |
| Irene Becklund PAO | Aug 14, 2026 | Tax withholding | −6,490 | $28.15 | $182.69K | 13,985 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 14, 2026 | Tax withholding | −16,147 | $28.15 | $454.54K | 65,734 |
| Deborah M. Autor Chief Policy Officer, Director | Aug 14, 2026 | Option exercise | +32,920 | – | – | 81,881 |
| Mohamed Elshenawy CTO | Aug 14, 2026 | Option exercise | +188,285 | – | – | 289,308 |
| Mohamed Elshenawy CTO | Aug 14, 2026 | Tax withholding | −95,798 | $28.15 | $2.70M | 193,510 |
| Christopher D. Payne Director | Aug 14, 2026 | Option exercise | +545 | – | – | 34,863 |
| Oluyemi Okupe Chief Financial Officer | Aug 14, 2026 | Option exercise | +71,616 | – | – | 300,554 |
| Oluyemi Okupe Chief Financial Officer | Aug 14, 2026 | Tax withholding | −36,437 | $28.15 | $1.03M | 264,117 |
| Kare Schultz Director | Aug 14, 2026 | Option exercise | +6,623 | – | – | 26,020 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Tax withholding | −10,201 | $28.15 | $287.16K | 197,847 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Option exercise | +25,927 | – | – | 208,048 |
| Patrick Harrison Carroll Chief Medical Officer | Aug 14, 2026 | Option exercise | +260 | – | – | 182,121 |
| Oluyemi Okupe Chief Financial Officer | Jul 17, 2026 | Option exercise | +7,163 | $5.01 | $35.89K | 291,484 |
| Oluyemi Okupe Chief Financial Officer | Jul 17, 2026 | Sale(10b5-1 plan) | −7,163 | $31.99 | $229.14K | 284,321 |
| Oluyemi Okupe Chief Financial Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −7,163 | $36.49 | $261.38K | 284,321 |
| Oluyemi Okupe Chief Financial Officer | Jul 6, 2026 | Option exercise | +7,163 | $5.01 | $35.89K | 291,484 |
| Oluyemi Okupe Chief Financial Officer | Jun 22, 2026 | Sale(10b5-1 plan) | −18,197 | $34.03 | $619.24K | 284,321 |
| Oluyemi Okupe Chief Financial Officer | Jun 22, 2026 | Option exercise | +6,376 | $5.01 | $31.94K | 302,518 |
| Oluyemi Okupe Chief Financial Officer | Jun 18, 2026 | Sale(10b5-1 plan) | −55,383 | $35.09 | $1.94M | 228,938 |
| Patrick Harrison Carroll Chief Medical Officer | Jun 18, 2026 | Sale(10b5-1 plan) | −23,726 | $35.00 | $830.41K | 181,861 |
| Michael Chi Chief Operating Officer | Jun 17, 2026 | Sale(10b5-1 plan) | −14,027 | $31.50 | $441.85K | 432,124 |
| Irene Becklund PAO | Jun 17, 2026 | Sale(10b5-1 plan) | −4,490 | $31.50 | $141.44K | 6,790 |
| Mohamed Elshenawy CTO | Jun 17, 2026 | Sale(10b5-1 plan) | −30,040 | $31.50 | $946.26K | 101,023 |
| Irene Becklund PAO | Jun 16, 2026 | Sale(10b5-1 plan) | −7,573 | $30.25 | $229.08K | 11,280 |
| Michael Chi Chief Operating Officer | Jun 15, 2026 | Option exercise | +86,264 | – | – | 493,850 |
| Michael Chi Chief Operating Officer | Jun 15, 2026 | Tax withholding | −47,699 | $30.17 | $1.44M | 446,151 |
| Soleil Boughton Chief Legal Officer | Jun 15, 2026 | Option exercise | +42,261 | – | – | 341,629 |
| Soleil Boughton Chief Legal Officer | Jun 15, 2026 | Tax withholding | −23,315 | $30.17 | $703.41K | 318,314 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Jun 15, 2026 | Tax withholding | −85,632 | $30.17 | $2.58M | 957,043 |
| Andrew Dudum Chief Executive Officer, Director, 10% owner | Jun 15, 2026 | Option exercise | +154,991 | – | – | 1,042,675 |
| Deborah M. Autor Chief Policy Officer, Director | Jun 15, 2026 | Option exercise | +32,919 | – | – | 64,357 |
| Deborah M. Autor Chief Policy Officer, Director | Jun 15, 2026 | Tax withholding | −15,396 | $30.17 | $464.50K | 48,961 |
| Irene Becklund PAO | Jun 15, 2026 | Tax withholding | −5,870 | $30.17 | $177.10K | 18,853 |
| Irene Becklund PAO | Jun 15, 2026 | Option exercise | +15,971 | – | – | 24,723 |
| Mohamed Elshenawy CTO | Jun 15, 2026 | Option exercise | +282,597 | – | – | 282,597 |
| Mohamed Elshenawy CTO | Jun 15, 2026 | Tax withholding | −151,534 | $30.17 | $4.57M | 131,063 |
| Patrick Harrison Carroll Chief Medical Officer | Jun 15, 2026 | Tax withholding | −8,310 | $30.17 | $250.71K | 205,587 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Soleil Boughton Officer | Oct 14, 2026 | 3,461 | $100.58K | Oct 14, 2026 | Restricted Stock Vesting |
| Oluyemi Okupe Officer | Oct 1, 2026 | 2,000 | $59.40K | Oct 1, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 30, 2026 | 3,461 | $100.96K | Sep 30, 2026 | Restricted Stock Vesting |
| Oluyemi Okupe Officer | Sep 22, 2026 | 29,277 | $876.85K | Sep 22, 2026 | Stock Option Exercise |
| Oluyemi Okupe Officer | Sep 17, 2026 | 12,313 | $354.86K | Sep 17, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 16, 2026 | 6,236 | $173.73K | Sep 16, 2026 | Restricted Stock Vesting |
| Mohamed Elshenawy Officer | Sep 15, 2026 | 7,954 | $225.81K | Sep 15, 2026 | Restricted Stock Vesting |
| Michael Chi Officer | Sep 15, 2026 | 14,027 | $398.23K | Sep 15, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Sep 2, 2026 | 3,458 | $97.97K | Sep 2, 2026 | Restricted Stock Vesting |
| Soleil Boughton Officer | Aug 19, 2026 | 25,111 | $691.81K | Aug 19, 2026 | Restricted Stock Vesting |
| Deborah M. Autor Officer, Director | Aug 18, 2026 | 16,773 | $467.13K | Aug 18, 2026 | Restricted Stock Vesting |
| Christiane Pendarvis Former Director | Jul 22, 2026 | 3,500 | $113.28K | Jul 22, 2026 | Restricted Stock Vesting |
| Okupe Oluyemi Officer | Jul 6, 2026 | 28,652 | $1.10M | Jul 6, 2026 | Acquired as compensation -- Stock Options |
| Patrick Harrison Carroll Officer | Jun 18, 2026 | 23,726 | $830.41K | Jun 18, 2026 | Restricted Stock Vesting |
| Irene Becklund Officer | Jun 17, 2026 | 4,490 | $141.44K | Jun 17, 2026 | Restricted Stock Vesting |